Invention Grant
- Patent Title: Biaryl amide compounds as kinase inhibitors
- Patent Title (中): 二芳基酰胺化合物作为激酶抑制剂
-
Application No.: US14204823Application Date: 2014-03-11
-
Publication No.: US09242969B2Publication Date: 2016-01-26
- Inventor: Paul A. Barsanti , Matthew Burger , Yan Lou , Gisele Nishiguchi , Valery Polyakov , Savithri Ramurthy , Alice Rico , Lina Setti , Aaron Smith , Benjamin Taft , Huw Tanner , Alan DiPesa , Naeem Yusuff
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D403/04 ; A61K31/5377 ; A61K31/541 ; C07D413/04 ; A61K45/06 ; C07D213/74 ; C07D237/20 ; C07D239/42 ; C07D239/47 ; C07D239/48 ; C07D277/42 ; C07D401/12 ; C07D413/12 ; C07D413/14 ; C07D417/12 ; C07D493/10 ; C07D403/12 ; C07D401/14 ; C07D405/14 ; C07D213/75 ; C07D233/88 ; C07D405/04 ; C07D405/12 ; C07D241/20 ; C07D471/04 ; C07D487/04 ; C07D263/58 ; C07D491/107 ; C07D493/04 ; C07D495/04 ; C07D498/08 ; C07D513/04
Abstract:
The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
Public/Granted literature
- US20140275003A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Public/Granted day:2014-09-18
Information query
